AMENDMENT TO THE FINISHED PRODUCT SUPPLY AGREEMENTThe Finished Product Supply Agreement • November 14th, 2005 • Barrier Therapeutics Inc • Pharmaceutical preparations
This Amendment (the “Amendment”) is made and entered into as of August 26, 2005 by and between Janssen Pharmaceutica, NV, a business corporation organized under the Laws of Belgium, having its principal office at B-2340 Beerse, Turnhoutseweg 30, Belgium (hereinafter referred to as “Janssen”) and Barrier Therapeutics, Inc., a Delaware corporation having an address at 600 College Road East, Suite 3200, Princeton, New Jersey 08540 (hereinafter referred to as “Barrier”).
